ChartWise Medical Systems Recognized on the Inc. 5000 List as One of America's Fastest-Growing Private Companies
18 août 2016 08h30 HE
|
ChartWise Medical Systems, Inc.
WAKEFIELD, RI--(Marketwired - August 18, 2016) - ChartWise Medical Systems, Inc. (www.chartwisemed.com), the award-winning industry leader in Computer-Assisted Clinical Documentation Improvement...
Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection
20 juin 2016 12h30 HE
|
Summit Therapeutics PLC
Microbiome-Sparing Action of Ridinilazole associated with Superiority over Vancomycin in Sustained Clinical Response Rate OXFORD, United Kingdom, June 20, 2016 (GLOBE NEWSWIRE) -- Summit...
Summit to Present Phase 2 CoDIFy Trial Data Highlighting Ridinilazole's Preservation of the Microbiome in CDI Patients at ASM Microbe 2016
23 mai 2016 07h00 HE
|
Summit Therapeutics plc
OXFORD, United Kingdom, May 23, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...
Positive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infection
11 avr. 2016 07h00 HE
|
Summit Therapeutics plc
OXFORD, United Kingdom, April 11, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular...
Summit Therapeutics Announces Publication of Preclinical Data Showing Ridinilazole Outperformed Standard of Care in Reducing C. Difficile Toxins That Drive Disease Symptoms
24 févr. 2016 07h00 HE
|
Summit Therapeutics plc
OXFORD, United Kingdom, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne...
ChartWise Medical Systems Scores Again With Best in KLAS Report Award Win
17 févr. 2016 08h30 HE
|
ChartWise Medical Systems, Inc.
WAKEFIELD, RI--(Marketwired - February 17, 2016) - ChartWise Medical Systems, Inc. (www.chartwisemed.com), the industry leader in Computer-Assisted Clinical Documentation Improvement (CACDI)...
Summit Therapeutics Granted Key European Patent for Novel Antibiotic Ridinilazole for Treatment of C. Difficile Infection
19 janv. 2016 07h00 HE
|
Summit Therapeutics plc
OXFORD, UK, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and...
Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2015 and Operational Progress
17 déc. 2015 07h00 HE
|
Summit Therapeutics plc
OXFORD, United Kingdom, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...
Three Associa CDI Managers Earn Industry Certification
24 nov. 2015 12h03 HE
|
Associa
GOLDEN VALLEY, Minn., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Community Development, Inc. (CDI), an Associa company, is proud to announce that three of its association managers recently attained their...
Center for Diagnostic Imaging Partners with Lexmark to Create National Medical Image Exchange
18 nov. 2015 14h53 HE
|
Lexmark International, Inc.
LEXINGTON, Ky., Nov. 18, 2015 (GLOBE NEWSWIRE) -- News Facts
Lexmark Healthcare and Center for Diagnostic Imaging (CDI) jointly announce the availability of a National Image Exchange that...